Generex Biotechnology Raises $2M in Conv Preferred at 25% Discount.

Generex Biotechnology Corporation (GNBT) announced that it has raised $2,075,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.03 per share, an approximate 25% discount to the market price ($0.04) of GNBT at deal announcement. A series of 69,166,667 60-Month Warrants with an exercise price of $0.03 per share (25% discount) was issued to the investors in this transaction. The transaction is expected to close on March 27, 2014. via PlacementTracker.

Advaxis Closes $12.2M CMPO at 26% Discount via Aegis, Noble

Advaxis Inc. (ADXS) announced that it has raised $12,240,000 in a CMPO/Overnight transaction. The common stock was sold at $3.00 per share, an approximate 26% discount to the market price ($4.08) of ADXS at deal announcement. Aegis Capital Corporation acted as Sole Book-Running Manager and Noble Financial Group acted as Co-Manager on the transaction. Underwriter counsel was Blank Rome LLP and issuer counsel was Reed Smith, LLP. via PlacementTracker.

Cadus Corp. Announces Rights Offering

Cadus Corporation (KDUS) announced a Rights Offering transaction. The Total Rights Offered is 13,144,040. Issuer counsel was Morrison Cohen, LLP. Further details have yet to be disclosed. via PlacementTracker.

Islet Sciences Raises $1.5M at 38% Discount

Islet Sciences, Inc. (ISLT) announced that it has raised $1,527,500 in a Common Stock transaction. The common stock was sold at $0.25 per share, an approximate 38% discount to the market price ($0.40) of ISLT at deal announcement. A series of 3,055,000 Warrants with an exercise price of $0.35 per share (12.5% discount) was issued to the investors in this transaction. The transaction funded in tranches from 03/14/2014 to 03/20/2014. via PlacementTracker.